Ann: Seminal study for central pressures in clini, page-5

re: Ann: Seminal study for central pressures ... Yep, hopefully we have flushed out Aust Ethical of their remaining shares (if it was them selling) and can now bust through that overhang that has been there for a long time now.

One of the cheapest and most promising companies within the health/bio sector, very low market cap compared to a majority out there who are nowhere near having done the ground work ACG have. The earnings potential here is just as great if not greater than many other companies within the sector who's market caps are 3x, 5x even 10x ACG's.

Looking forward to some meaty contracts to come our way before years end.